Linked e-resources
Details
Table of Contents
Intro; Preface; Contents; Chapter 1: New-Onset LV Dysfunction; 1.1 Approach; 1.2 Case Resolution; References; Chapter 2: Restrictive Cardiomyopathy; 2.1 Background; 2.2 Prognosis; 2.3 Clinical Presentation; 2.4 Imaging; 2.5 Treatment; 2.6 Mechanical Circulatory Support; 2.7 Cardiac Transplantation; 2.8 Conclusion; References; Chapter 3: Acute Decompensated Heart Failure; 3.1 What is Critical in the Initial Assessment of Acute Decompensated Heart Failure (ADHF)?; 3.2 How Should Patients in Profile C Be Managed?; 3.3 How Can Parenteral Inotropes or Vasodilators Be Weaned?; References
Chapter 4: Valvular Disease and Heart Failure: Mitral Regurgitation4.1 Discussion; 4.2 Stage 1: Can My Patient Tolerate Optimal Medical Therapy? Is He/She Medically Optimized?; 4.3 Step 2: My Patient Cannot Be Optimized Further. What About Surgical or Percutaneous Mitral Valve Repair? Are More Advanced Therapies Appropriate?; References; Chapter 5: Valvular Disease and Heart Failure: Aortic Stenosis; 5.1 Discussion; References; Chapter 6: Low Output Heart Failure; 6.1 Discussion; References; Chapter 7: Management of Stage D Heart Failure; 7.1 Case Discussion; 7.1.1 Background
7.1.2 Advanced Heart Failure Assessment7.1.3 Advanced Heart Failure Management; References; Chapter 8: Heart Failure with Preserved Ejection Fraction; 8.1 Step 1: What is the Cause of Exertional Dyspnea? Does My Patient Have "Heart Failure with Preserved Ejection Fraction" (HFpEF)?; 8.2 Step 2: How Can Invasive Hemodynamic Testing Be Utilized in the Diagnosis of HFpEF?; References; Chapter 9: Management of Cardiogenic Shock; 9.1 What is the Current Diagnosis? What are the Next Steps in Management?
9.2 Why is the Patient Still Dependent on Circulatory Support? What is the Next Step in Management?9.3 Conclusion; Appendix; IABP Counterpulsation; Temporary Ventricular Assist Devices; Impella; Tandem Heart; Centrimag; References; Index
Chapter 4: Valvular Disease and Heart Failure: Mitral Regurgitation4.1 Discussion; 4.2 Stage 1: Can My Patient Tolerate Optimal Medical Therapy? Is He/She Medically Optimized?; 4.3 Step 2: My Patient Cannot Be Optimized Further. What About Surgical or Percutaneous Mitral Valve Repair? Are More Advanced Therapies Appropriate?; References; Chapter 5: Valvular Disease and Heart Failure: Aortic Stenosis; 5.1 Discussion; References; Chapter 6: Low Output Heart Failure; 6.1 Discussion; References; Chapter 7: Management of Stage D Heart Failure; 7.1 Case Discussion; 7.1.1 Background
7.1.2 Advanced Heart Failure Assessment7.1.3 Advanced Heart Failure Management; References; Chapter 8: Heart Failure with Preserved Ejection Fraction; 8.1 Step 1: What is the Cause of Exertional Dyspnea? Does My Patient Have "Heart Failure with Preserved Ejection Fraction" (HFpEF)?; 8.2 Step 2: How Can Invasive Hemodynamic Testing Be Utilized in the Diagnosis of HFpEF?; References; Chapter 9: Management of Cardiogenic Shock; 9.1 What is the Current Diagnosis? What are the Next Steps in Management?
9.2 Why is the Patient Still Dependent on Circulatory Support? What is the Next Step in Management?9.3 Conclusion; Appendix; IABP Counterpulsation; Temporary Ventricular Assist Devices; Impella; Tandem Heart; Centrimag; References; Index